Statement Of Cash Flows [Abstract]

ABIONYX Pharma - Filing #2821124

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
2 729 EUR
2 646 EUR
Increase (decrease) in working capital
2 130 EUR
1 304 EUR
Adjustments for amortisation expense
22,000 EUR
13,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.